EW vs ISRG vs ALC Stock Comparison

Edwards Lifesciences, Intuitive Surgical and Alcon Prices as of Nov 13, 2026 Peers: Industry group
EW Edwards Lifesciences Corp
$107.18 +24.0% 1M +24.5% 1Y
Market cap
$61.46B
P/E
60.6x
Revenue (TTM)
$6.67B
Div. yield
–
Medical Devices Healthcare
3 wins
ISRG Intuitive Surgical Inc
$443.59 +5.6% 1M -21.6% 1Y
Market cap
$153.38B
P/E
51.9x
Revenue (TTM)
$11.58B
Div. yield
–
Medical Devices Healthcare
6 wins
ALC Alcon Inc
$74.13 +16.0% 1M -5.7% 1Y
Market cap
$36.37B
P/E
54.6x
Revenue (TTM)
$10.93B
Div. yield
–
Medical Devices Healthcare
1 win

Head to Head

10 decided of 12

Intuitive Surgical leads on 6 of the 12 questions below (Intuitive Surgical 6, Edwards Lifesciences 3, Alcon 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionEWISRGALCLeader
Larger companyMarket capitalisation $61.46B $153.38B $36.37B ISRG
Cheaper on earningsLower P/E, profitable companies only 60.6x 51.9x 54.6x ISRG
Cheaper on forward earningsLower price / next fiscal year consensus EPS 37.6x 38.5x 23.0x ALC
Faster revenue growthRevenue growth, trailing twelve months +13.4% +20.5% +8.0% ISRG
More profitableNet margin, trailing twelve months 15.2% 25.5% 6.1% ISRG
Better return on capitalReturn on invested capital 8.7% — 3.8% EW
Less leveragedLower net debt / EBITDA -2.5x — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +24.5% -21.6% -5.7% EW
Better 5-year returnAnnualised price return, 5 years -1.6%/yr +4.6%/yr -1.8%/yr ISRG
Less volatileAnnualised volatility, 1 year 25.5% 36.1% 29.5% EW
Higher overall scoreMean of the five percentile scores vs peers 77/100 81/100 67/100 ISRG

Percentile Scorecard

EWISRGALC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisEWISRGALC
Valuation 61 #96 of 243 52 #118 of 243 77 #57 of 243
Growth 57 #99 of 228 81 #45 of 228 45 #126 of 228
Profitability 96 #10 of 222 97 #7 of 222 78 #49 of 222
Financial Health 87 #34 of 248 81 #47 of 248 64 #89 of 248
Shareholder Returns 84 #26 of 158 95 #9 of 158 71 #46 of 158
Overall 77 81 67
  • EW ranked among 252 companies in Medical Devices and Diagnostics
  • ISRG ranked among 252 companies in Medical Devices and Diagnostics
  • ALC ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodEWISRGALCSPY
1 month +24.0%+5.6%+16.0% -2.0%
3 months +17.0%+12.4%-0.2% -2.8%
6 months +31.7%+5.3%+16.5% +2.0%
Year to date +25.7%-21.7%-5.9% +10.6%
1 year +24.5%-21.6%-5.7% +12.2%
3 years +62.9%+52.1%-1.1% +68.1%
3 years, per year +17.7%+15.0%-0.4% +18.9%
5 years -7.6%+25.0%-8.7% +61.4%
5 years, per year -1.6%+4.6%-1.8% +10.1%
10 years +253.3%+542.1%— +248.5%
10 years, per year +13.5%+20.4%— +13.3%

Risk

MeasureEWISRGALCSPY
Volatility, 1Y 25.5%36.1%29.5% 13.6%
Downside volatility, 1Y 24.7%38.4%29.2% 13.9%
Beta vs S&P 500, 1Y 0.580.920.37 1.00
Return / volatility, 1Y 0.96-0.60-0.19 0.90
Max drawdown, 5Y -54.3%-49.9%-38.4% -25.4%
From 52-week high 0.0%-25.2%-15.0% -3.2%
52-week high $107.18$592.85$87.18 $779.14
52-week low $75.87$332.02$62.02 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleEWISRGALC
P/E now vs peer median 60.9xmedian 26.5x 52.4xmedian 26.5x 54.9xmedian 26.5x
P/S now vs peer median 9.2xmedian 2.7x 13.3xmedian 2.7x 3.3xmedian 2.7x
EV/EBITDA now vs peer median 35.8xmedian 18.4x 36.6xmedian 18.4x —median 18.4x
P/FCF now vs peer median 43.3xmedian 25.4x 42.7xmedian 25.4x 20.4xmedian 25.4x
P/B now vs peer median 5.6xmedian 2.5x 9.5xmedian 2.5x 1.7xmedian 2.5x
PEG now vs peer median -6.65median 0.98 2.04median 0.98 3.97median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsEWISRGALC
Revenue $6.67B $11.58B $10.93B
Gross profit $5.21B $7.78B $6.34B
Operating income $1.44B $3.28B $997.00M
Net income $1.02B $2.97B $666.00M
Free cash flow $1.42B $3.60B $1.77B
R&D $1.09B $1.49B $1.44B
EPS (diluted) $1.76 $8.41 $1.34
Cash & equivalents $3.11B $2.98B $1.71B
Total debt $598.80M – $4.69B
Shares (diluted) 577.60M 351.60M 496.20M
Enterprise value $44.67B $133.67B $27.08B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricEWISRGALC
P/E 60.9x 52.4x 54.9x
P/FCF 43.3x 42.7x 20.4x
P/Operating cash flow 35.9x 37.6x 15.4x
P/S 9.2x 13.3x 3.3x
P/B 5.6x 9.5x 1.7x
P/Tangible book 6.3x 10.3x 2.7x
EV/EBITDA 35.8x 36.6x –
EV/EBIT 40.0x 45.6x 38.4x
EV/Revenue 8.6x 12.9x 3.5x
EV/FCF 40.5x 41.6x 21.6x
EV/Operating cash flow 33.6x 36.6x 16.3x
PEG (3Y EPS CAGR) -6.65 2.04 3.97

Growth

14 metrics
MetricEWISRGALC
Revenue growth (1Y) 13.4% 20.5% 8.0%
Revenue CAGR (3Y) 16.9% 19.1% 5.6%
Gross profit growth (1Y) 13.2% 21.9% 12.9%
Gross profit CAGR (3Y) 13.7% 19.5% 7.3%
Operating income growth (1Y) 1.1% 16.6% -30.9%
Operating income CAGR (3Y) 5.8% 24.8% 5.4%
Net income growth (1Y) -25.2% 7.5% -36.4%
Net income CAGR (3Y) -10.6% 24.4% 14.0%
EPS growth (1Y) -24.5% 10.8% -37.1%
EPS CAGR (3Y) -9.2% 25.7% 13.8%
Operating cash flow growth (1Y) 68.9% 38.1% 13.3%
Operating cash flow CAGR (3Y) 18.1% 26.4% 22.3%
Free cash flow growth (1Y) 77.1% 58.4% 7.5%
Free cash flow CAGR (3Y) 20.8% 42.0% 44.0%

Profitability

14 metrics
MetricEWISRGALC
Gross margin 78.0% 67.2% 58.0%
EBITDA margin 24.2% 35.3% –
Operating margin 21.6% 28.4% 9.1%
Pretax margin 21.5% 31.3% 7.2%
Net margin 15.2% 25.5% 6.1%
FCF margin 21.3% 31.1% 16.2%
Operating cash flow margin 25.7% 35.3% 21.5%
Return on equity 9.4% 17.3% 3.1%
Return on assets 7.2% 14.8% 2.1%
Return on invested capital 8.7% – 3.8%
Return on capital employed 11.6% 18.7% 3.5%
Asset turnover 0.5x 0.6x 0.3x
Cash conversion (OCF / net income) 1.7x 1.4x 3.5x
Stock comp / revenue 2.6% 7.2% 1.5%

Financial Health

11 metrics
MetricEWISRGALC
Debt / assets 4.2% – 14.9%
Debt / equity 0.1x – 0.2x
Net debt / EBITDA -2.5x – –
Debt / FCF 0.4x – 2.6x
Liabilities / assets 22.5% 16.7% 30.7%
Equity / assets 77.5% 83.3% 69.3%
Interest coverage – – 9.6x
Current ratio 4.6x 3.3x 2.5x
Quick ratio 3.5x 2.3x 1.6x
Cash ratio 2.9x 1.6x 0.9x
Altman Z-score 14.42 30.40 –

Shareholder Returns

7 metrics
MetricEWISRGALC
Dividend yield – – 0.4%
Net buyback yield 0.9% 2.8% 1.3%
Shareholder yield 0.9% 2.8% 1.7%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusEWISRGALC
Forward P/E 37.6xFY2026 38.5xFY2026 23.0xFY2026
EPS, next fiscal year $2.85FY2026 $11.52FY2026 $3.22FY2026
EPS growth, next FY +11.3%FY2026 +29.0%FY2026 +7.7%FY2026
EPS growth, the year after +12.6% +4.5% +14.0%
Revenue, next fiscal year $7.28BFY2026 $11.62BFY2026 $10.48BFY2026
Revenue growth, next FY +19.9%FY2026 +15.5%FY2026 +4.1%FY2026
Revenue growth, the year after -2.2% +11.3% +7.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersEWISRGALC
Held by institutions 90.6% 86.2% 48.8%
Institutions holding 1,326 2,241 631
Change in shares held, QoQ +20.4% +4.6% +5.3%
Institutions buying 641 1,073 226
Institutions selling 456 879 274
Buyers to sellers 1.41 1.22 0.82

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

EWISRGALC
EW 1.00 0.48 0.34
ISRG 0.48 1.00 0.44
ALC 0.34 0.44 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, EW, ISRG and ALC?

Intuitive Surgical (ISRG) is the largest by market capitalisation: Edwards Lifesciences (EW) $61.46B, Intuitive Surgical (ISRG) $153.38B, Alcon (ALC) $36.37B.

Which stock is cheaper, EW, ISRG and ALC?

Intuitive Surgical (ISRG) trades on the lowest price-to-earnings ratio (Edwards Lifesciences (EW) 60.6x, Intuitive Surgical (ISRG) 51.9x, Alcon (ALC) 54.6x). On next year's consensus earnings, Alcon (ALC) is cheapest (Edwards Lifesciences (EW) 37.6x, Intuitive Surgical (ISRG) 38.5x, Alcon (ALC) 23.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Intuitive Surgical (ISRG) grew revenue fastest over the trailing twelve months: Edwards Lifesciences (EW) +13.4%, Intuitive Surgical (ISRG) +20.5%, Alcon (ALC) +8.0%.

Which company is more profitable?

Intuitive Surgical (ISRG) has the highest net margin (Edwards Lifesciences (EW) 15.2%, Intuitive Surgical (ISRG) 25.5%, Alcon (ALC) 6.1%). On return on invested capital, Edwards Lifesciences (EW) leads (Edwards Lifesciences (EW) 8.7%, Alcon (ALC) 3.8%).

Which stock has performed better?

Over the past year Edwards Lifesciences (EW) returned the most: Edwards Lifesciences (EW) +24.5%, Intuitive Surgical (ISRG) -21.6%, Alcon (ALC) -5.7%. Over five years, Intuitive Surgical (ISRG) compounded fastest (Edwards Lifesciences (EW) -1.6%/yr, Intuitive Surgical (ISRG) +4.6%/yr, Alcon (ALC) -1.8%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Edwards Lifesciences (EW) has been the steadiest (Edwards Lifesciences (EW) 25.5%, Intuitive Surgical (ISRG) 36.1%, Alcon (ALC) 29.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, EW, ISRG and ALC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Intuitive Surgical (ISRG) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.